CD163 and pancreatic neoplasm: One study observed that CD14+ human peripheral blood mononuclear cells (PBMCs), when co-cultured with fibroblasts from pancreatic cancer tissue, exhibited an increased expression of M2 macrophage phenotype markers CD163 and CD206 [35].